IRESS (ASX:IRE) share price rockets 16% on new takeover proposal

IRESS has received another takeover approach. Second time lucky?

| More on:
These three ASX mining shares rocketed by more than 20% today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The IRESS Ltd (ASX: IRE) share price is far and away the best performer on the S&P/ASX 200 Index (ASX: XJO) on Thursday.

In morning trade, the financial technology company's shares were up as much as 16% to $14.54.

The IRESS share price has dropped back a touch since then but currently remains 13% higher at $14.15.

Why is the IRESS share price rocketing higher?

Investors have been bidding the IRESS share price higher today after it revealed the receipt of a takeover approach from earlier this month.

According to the release, on 4 July EQT Fund Management made a confidential, unsolicited, non-binding and indicative proposal to acquire IRESS via a scheme of arrangement at a price of between $15.30 and $15.50 cash per share. This represents a 22.3% to 23.9% premium to the IRESS share price at yesterday's close.

This is the second offer that EQT Fund Management has made, with IRESS rejecting a $14.80 per share proposal received on 18 June. The IRESS Board rejected that offer as it was not considered to be in the best interests of shareholders.

What about the latest offer?

IRESS revealed that following careful consideration, including obtaining advice from its financial and legal advisers, the IRESS Board unanimously concluded that the new proposal was conditional and did not represent compelling value for shareholders.

However, it did inform EQT Fund Management that it was prepared to provide it with access to limited non-public information. This is so EQT can develop a proposal that is capable of being recommended to shareholders. This information has now been shared with EQT after the two parties entered into a confidentiality and standstill agreement.

While discussions are continuing, management warned that there is no certainty that they will result in a revised proposal from EQT.

As a result, the IRESS Board recommends that shareholders take no action in relation to the proposal. In the meantime, the company will continue to keep shareholders and the market informed of developments.

The IRESS share price is now up 32% in 2021.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »